PREP in Neurodegenerative Disorders
Stopping Alzheimer's and Parkinson's disease
We are studying the role of prolyl oligopeptidase (PREP, formerly known as POP) on disease progression and neuronal toxicity in neurodegenerative disorders with protein aggregation. These disorders involve several serious diseases such as Alzheimer’s and Parkinson’s diseases, and several more rare neurodegenerative conditions. Based on PREP inhibitors, we are developing novel and disease-modifying drug therapies to stop the neuronal death in Alzheimer's and Parkinson's diseases.
Recent news from PREP lab
New personnel in PREP lab!
It's time to welcome new personnel to PREP as Francesca de Lorenzo and Veera Kulmala started working in our lab on 1.6.2020
New article out to Biomedicine&Pharmacotherapy
PREP lab got another publication as our manuscript "The effect of prolyl oligopeptidase inhibitors on alpha-synuclein aggregation and autophagy...
Neurodegenerative diseases, such as Alzheimer's and Parkinson's disease, are progressive diseases where neuronal death in brain causes...
We are happy to share our research results. If you are interested in our publications but cannot find a copy, please do not hesitate to...
We are a dynamic group of researchers with a strong focus on finding novel disease modifying therapies for neurodegerative diseases...